Merck India signed a Memorandum of Understanding (MOU) with JSS Academy of Higher Education & Research, Mysuru (JSS AHER) recently, in the presence of Dr. B. Suresh, the Pro Chancellor, JSS AHER, Mysuru and former president of Pharmacy Council of India (PCI). This is an exciting step forward in strengthening industry-academia collaboration in healthcare research and capability building. 

As part of this partnership, the Merck Healthcare R&D India has also launched the CATALYST program at JSS AHER. The Catalyst program is specially designed to develop industry-ready capabilities among students from healthcare and life science backgrounds with focus on critical R&D functions such as Pharmacovigilance, Medical Writing, Regulatory Affairs, Scientific Writing, and Soft Skills Development. It provides a platform to engage with young minds and reaffirm Merck Healthcare R&D India's commitment to advancing scientific innovation through collaborative learning.

Last year too, Merck Healthcare R&D India successfully completed the Catalyst Program with over 20 bright life science students from Dayananda Sagar University. This initiative will mark a significant a step towards strengthening academia-industry partnerships and will enhance the skills and knowledge of all participants, paving the way for future innovations in healthcare.